1. Current status in cancer cell reprogramming and its clinical implications

   • Kenan Izgi
   • Halit Canatan
   • Banu Iskender

   Review – Cancer Research 12 September 2016 Pages: 371 - 383

   

2. HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer

   • Wen-Jin Ding
   • Min Zhou
   • Chun-Ying Qu

   Original Article – Cancer Research 19 October 2016 Pages: 385 - 397

   

3. A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients

   • Kaname Miyashita
   • Kei Fujii
   • Naokuni Uike

   Original Article – Cancer Research Open access 25 October 2016 Pages: 399 - 408

   

4. Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases

   • Jian-Xia Jiang
   • Qing Liu
   • Shun-Fu Xu

   Original Article – Cancer Research 10 November 2016 Pages: 409 - 418

   

5. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM–CHK2–P53 pathway

   • Jing Yao
   • Ai Huang
   • Hong Ma

   Original Article – Cancer Research 12 November 2016 Pages: 419 - 431

   

6. Expression of PIWIL3 in primary and metastatic melanoma

   • Thilo Gambichler
   • Christina Kohsik
   • Michael Sand

   Original Article – Cancer Research 17 November 2016 Pages: 433 - 437

   

7. Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma

   • Thomas M. Atkinson
   • Jennifer L. Hay
   • Richard D. Carvajal

   Original Article – Cancer Research 05 December 2016 Pages: 439 - 445

8. BRAF V600E-dependent role of autophagy in uveal melanoma

   • Yinu Zhao
   • Weibin Wang
   • Thomas J. Fahey III

   Original Article – Cancer Research 07 December 2016 Pages: 447 - 455

   

9. Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT

   • Tao Liu
   • Shenghao Wang
   • Huilin Yang

   Review – Clinical Oncology 17 October 2016 Pages: 457 - 465

   

10. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis

    • San-Gang Wu
    • Feng-Yan Li
    • Zhen-Yu He

    Original Article – Clinical Oncology 03 November 2016 Pages: 467 - 474

    

11. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99^m with blue dye versus indocyanine green fluorescent dye

    • Andrea Papadia
    • Ignacio Zapardiel
    • Alessandro Buda

    Original Article – Clinical Oncology 03 November 2016 Pages: 475 - 480

    

12. Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results

    • Zhongzhi Jia
    • Ricardo Paz-Fumagalli
    • Weiping Wang

    Original Article – Clinical Oncology 08 November 2016 Pages: 481 - 489

    

13. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?

    • Andrea Papadia
    • Maria Luisa Gasparri
    • Michael D. Mueller

    Original Article – Clinical Oncology 11 November 2016 Pages: 491 - 497

14. Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma

    • Liangyou Gu
    • Hongzhao Li
    • Xu Zhang

    Original Article – Clinical Oncology 14 November 2016 Pages: 499 - 508

    

15. Survival of de novo stage IV breast cancer patients over three decades

    • Dieter Hölzel
    • Renate Eckel
    • Jutta Engel

    Original Article – Clinical Oncology 16 November 2016 Pages: 509 - 519

    

16. Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis

    • Theodoros Tokas
    • Margaritis Avgeris
    • Constantinos A. Constantinides

    Original Article – Clinical Oncology 17 November 2016 Pages: 521 - 532

    

17. Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)

    • Andrea Forschner
    • Felizitas Eichner
    • Thomas Kurt Eigentler

    Original Article – Clinical Oncology 22 November 2016 Pages: 533 - 540

    

18. A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)

    • Jalid Sehouli
    • Oliver Tomè
    • Gerald Gitsch

    Original Article – Clinical Oncology Open access 28 November 2016 Pages: 541 - 550

    

19. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer

    • Isao Oze
    • Shu Shimada
    • Yasuhito Yuasa

    Letter to the Editor 01 December 2016 Pages: 551 - 554